Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

NCT00586807 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT00586807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Response to Infliximab in Pediatric Ulcerative Colitis
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2005
Completion date
September 30, 2008
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

energy expenditure, protein metabolism, ulcerative colitis